Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression-Reference-Cited by-同舟云学术

Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression

Published:2021-12-20 Issue:2 Volume:113 Page:478-488
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Zhao Tong‐Chao¹²³^ORCID,Zhou Zhi‐Hang¹²³,Ju Wu‐Tong¹²³,Liang Si‐Yuan¹²³,Tang Xiao¹²³,Zhu Dong‐Wang¹²³,Zhang Zhi‐Yuan¹²³,Zhong Lai‐Ping¹²³

Affiliation:

1. Department of Oral and Maxillofacial‐Head and Neck Oncology College of Stomatology Ninth People’s HospitalShanghai Jiao Tong University School of Medicine Shanghai China

2. National Clinical Research Center for Oral Diseases Shanghai China

3. Shanghai Key Laboratory of Stomatology Shanghai China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15218

Reference28 articles.

1. Cancer Statistics, 2021

2. Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions

3. Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma